Prokaryotic 2-component signaling pathways for use as logic gates in mammalian cells

US10160978B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10160978-B2
Application numberUS-201515316169-A
CountryUS
Kind codeB2
Filing dateJun 4, 2015
Priority dateJun 5, 2014
Publication dateDec 25, 2018
Grant dateDec 25, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to mammalian cells comprising at least one prokaryotic two-component signaling (TCS) pathway comprised of an activator protein A, a response regulator (RR) protein B activated by said protein A, such activation leading to an activated RR protein B, and an output gene C operably linked to a promoter. Transcription from said promoter is activated by activated RR protein B, and the expression of output gene C defines at least a first state (0, no transcription) and a second state (1, detectable transcription). The invention further relates to logic gates designed from such cells, and methods for integrating a plurality of output signals based on the cells and logic gates of the invention.

First claim

Opening claim text (preview).

The invention claimed is: 1. An isolated mammalian cell comprising at least one prokaryotic two-component signaling (TCS) pathway comprised of i. an activator protein A, ii. a response regulator (RR) protein B activated by said protein A, such activation leading to an activated RR protein B, and iii. an output gene C operably linked to a promoter, wherein transcription of the transcription apparatus in said isolated mammalian cell from said promoter is activated by activated RR protein B, and expression of output gene C defines at least a first state 0, which designates no transcription, and a second state 1, which designates detectable transcription, and wherein said activator protein A is a sensor histidine kinase comprising a histidine residue, said RR protein B is a transcriptional regulator comprising an aspartic acid residue, and activation of said RR protein B by said activator protein A is effected by transfer of a phosphate from said histidine residue to said aspartic acid residue. 2. The isolated mammalian cell according to claim 1 , wherein pairs of the activator protein A and said RR protein B are selected from the group consisting of EnvZ-OmpR, NarX-NarL, DcuS-DcuR, PhoR-PhoB, SenX3-RegX3, PhoQ-PhoP, RstB-RstA, CpxA-CpxR, CssS-CssR, CreC-CreB, BaeS-BaeR, BasS-BasR,QseC-QseB, KdpD-KdpE, TorS-TorR, ArcB-ArcA, TctE-TctD, ResE-ResD, VicK-VicR, MprB-MprA, MtrB-MtrA, PrrB-PrrA, TrcS-TrcR, NrsS-NrsR, ManS-ManR, NblS-NblR, SasA-RpaAB, SaeS-SaeR, BceS-BceR, YxdK-YxdJ, NarQ-NarP, UhpB-UhpA, RcsC-RcsD-RcsB, BarA-UvrY, ComP-ComA, EvgS-EvgA, DegS-DegU, DesK-DesR, VraS-VraR, LiaS-LiaR, DevS-DevR, NreB-NreC, YdfH-YdfI, KinABCDE-Spo0FA, CitA-CitB, CitS-CitT, DctS-DctR, MalK-MalR, LytS-LytR, AlgZ-AlgR, NatK-NatR, AgrC-ArgA, ComD-ComE, GlnL-GlnG, NtrY-NtrX, HydH-HydG, AtoS-AtoC, PilS-PilR, GlrK-GlrR, PgtB-PgtA, DctB-DctD, KinB-AlgB, CheA-CheYBV, ChpA-ChB/PilGH, PixL-PixGH, WspE-WspRF, Cphl-Rcpl, PleC-PleD, CckA-CtrA/CpdR, LuxQN/CqsS-LuxU-LuxO, TtrS-TtrR, FlrB-FlrC, SLN1-YPD1-SSK1/SKN7, RpfC-RpfG, GlnK-GlnL, YesM-YesN, ChvG-ChvI, CiaH-CiaR, SalK-SalR, RegB-RegA and FixL-FixJ. 3. The isolated mammalian cell according to claim 1 , wherein said protein A and said RR protein B are codon-optimized for human cells. 4. The isolated mammalian cell according to claim 1 , wherein the output gene C encodes a fluorescent reporter, a protein or microRNA that affects the cell function or internal state. 5. The isolated mammalian cell according to claim 1 , wherein the output gene C is amcyan. 6. The isolated mammalian cell according to claim 1 , wherein the activator protein A can be constitutively active or activated by input signals. 7. The isolated mammalian cell according to claim 1 , wherein the input signals are selected from the group consisting of: quinones, nitrate, nitrite, citrate, isocitrate, fumarate, succinate, malate, indole, serine, aspartate, chemoattractants, oxygen, carbon monoxide, nitrous oxide, blue light, vancomycin, potassium, quorum sensing molecules, temperature change, sulfate ions, nicotinic acid, changes in osmolarity, toluene, O-xylene, glutamine, 2-ketoglutarate, and magnesium. 8. An engineered biological logic AND gate comprising the isolated mammalian cell according to claim 1 , wherein input 1 activates said activator protein A, input 2 activates said response regulator protein B and the output is the expression state of said output gene C. 9. The engineered biological logic AND gate according to claim 8 , wherein input 2 activates a second activator protein A′, which is able to activate a second RR protein B′ that enables transcription of the first response regulator protein B. 10. The engineered biological logic AND gate according to claim 8 , wherein input 1 and input 2 are stimuli selected from the group consisting of: quinones, nitrate, nitrite, citrate, isocitrate, fumarate, succinate, malate, indole, serine, aspartate, chemoattractants, oxygen, carbon monoxide, nitrous oxide, blue light, vancomycin, potassium, quorum sensing molecules, temperature change, sulfate ions, nicotinic acid, changes in osmolarity, toluene, O-xylene, glutamine, 2-ketoglutarate, magnesium and stimuli controlling expression of the components selected from transcription factors or microRNAs. 11. An engineered biological logic OR gate comprising the isolated mammalian cell according to claim 1 , wherein input 1 activates said activator protein A, input 2 activates a second activator protein A′ able to activate the same RR protein B as activator protein A and the output is the expression state of said output gene C. 12. An engineered biological logic NOR gate comprising the isolated mammalian cell according to claim 1 , wherein input 1 is an inhibitor A− of said activator protein A, input 2 is an inhibitor B− of said RR protein B and the output is the expression state of said output gene C. 13. An engineered biological logic NAND gate comprising the isolated mammalian cell according to claim 1 , wherein input 1 is an inhibitor A− of said activator protein A, input 2 is an inhibitor A′− of said activator protein A′ and the output is the expression state of said output gene C. 14. The isolated mammalian cell according to claim 1 , wherein pairs of the activator protein A and said RR protein B are selected from the group consisting of EnvZ-OmpR, NarX-NarL, and DcuS-DcuR.

Assignees

Inventors

Classifications

  • Escherichia (G) · CPC title

  • transferring phosphorus containing groups, e.g. kinases (2.7) · CPC title

  • Histidine kinase (2.7.13.3) · CPC title

  • from coelenteratae, e.g. medusae · CPC title

  • Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10160978B2 cover?
The invention relates to mammalian cells comprising at least one prokaryotic two-component signaling (TCS) pathway comprised of an activator protein A, a response regulator (RR) protein B activated by said protein A, such activation leading to an activated RR protein B, and an output gene C operably linked to a promoter. Transcription from said promoter is activated by activated RR protein B, a…
Who is the assignee on this patent?
Eth Zuerich
What technology area does this patent fall under?
Primary CPC classification C12N15/85. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).